Bellerophon Therapeutics, Inc.·4

Jan 25, 4:21 PM ET

Peacock Jonathan M 4

4 · Bellerophon Therapeutics, Inc. · Filed Jan 25, 2019

Insider Transaction Report

Form 4
Period: 2019-01-25
Peacock Jonathan M
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2019-01-25$0.70/sh+714,286$500,0001,855,920 total

Documents

1 file
  • 4
    wf-form4_154845128913147.xmlPrimary

    FORM 4